Clinical Trial Update: An Evaluation of 9MW1911 Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 evaluation of 9MW1911 Injection in healthy subjects has been completed, assessing safety in potential indications including asthma, chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atopic Dermatitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• 9MW1911 Injection (9MW1911)

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Asthma, COPD | Phase 1 | Status: COMPLETED